Pfizer boosts COVID shot forecasts by $2 billion
Pfizer boosts COVID shot forecasts by $2 billion
November 01, 2022
Pfizer raised its forecast for annual sales of its COVID vaccine to $34 billion on demand for Omicron-targeted boosters, helping allay some investor worries over growth for the vaccinations.
Post A Comment:
0 comments:
Leave a comment. Thanks!